 | • レポートコード：GIR-2104Z02562 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ブプレノルフィン経皮パッチのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ブプレノルフィン経皮パッチの種類別市場規模（5mcg/h、7.5mcg/h、10mcg/h、15mcg/h、20mcg/h）、用途別市場規模（がん性疼痛緩和、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ブプレノルフィン経皮パッチの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Grunenthal、PurduePharma、Luye Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：5mcg/h、7.5mcg/h、10mcg/h、15mcg/h、20mcg/h ・用途別分析2016年-2026年：がん性疼痛緩和、その他 ・ブプレノルフィン経皮パッチの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ブプレノルフィン経皮パッチのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ブプレノルフィン経皮パッチのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ブプレノルフィン経皮パッチの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ブプレノルフィン経皮パッチの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Buprenorphine Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Buprenorphine Transdermal Patches size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Buprenorphine Transdermal Patches market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Buprenorphine Transdermal Patches market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5mcg/h
7.5mcg/h
10mcg/h
15 mcg/h
20 mcg/h
Market segment by Application can be divided into
Relieve Cancer Pain
Other
The key market players for global Buprenorphine Transdermal Patches market are listed below:
Grunenthal
PurduePharma
Luye Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Buprenorphine Transdermal Patches Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Buprenorphine Transdermal Patches Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 5mcg/h
1.2.3 7.5mcg/h
1.2.4 10mcg/h
1.2.5 15 mcg/h
1.2.6 20 mcg/h
1.3 Market Analysis by Application
1.3.1 Overview: Global Buprenorphine Transdermal Patches Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Relieve Cancer Pain
1.3.3 Other
1.4 Global Buprenorphine Transdermal Patches Market Size & Forecast
1.4.1 Global Buprenorphine Transdermal Patches Sales in Value (2016-2026))
1.4.2 Global Buprenorphine Transdermal Patches Sales in Volume (2016-2026)
1.4.3 Global Buprenorphine Transdermal Patches Price by Type (2016-2026) & (US$/Unit)
1.5 Global Buprenorphine Transdermal Patches Production Capacity Analysis
1.5.1 Global Buprenorphine Transdermal Patches Total Production Capacity (2016-2026)
1.5.2 Global Buprenorphine Transdermal Patches Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Buprenorphine Transdermal Patches Market Drivers
1.6.2 Buprenorphine Transdermal Patches Market Restraints
1.6.3 Buprenorphine Transdermal Patches Trends Analysis
2 Manufacturers Profiles
2.1 Grunenthal
2.1.1 Grunenthal Details
2.1.2 Grunenthal Major Business
2.1.3 Grunenthal Buprenorphine Transdermal Patches Product and Services
2.1.4 Grunenthal Buprenorphine Transdermal Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 PurduePharma
2.2.1 PurduePharma Details
2.2.2 PurduePharma Major Business
2.2.3 PurduePharma Buprenorphine Transdermal Patches Product and Services
2.2.4 PurduePharma Buprenorphine Transdermal Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Luye Pharma
2.3.1 Luye Pharma Details
2.3.2 Luye Pharma Major Business
2.3.3 Luye Pharma Buprenorphine Transdermal Patches Product and Services
2.3.4 Luye Pharma Buprenorphine Transdermal Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Buprenorphine Transdermal Patches Sales by Manufacturer
3.1 Global Buprenorphine Transdermal Patches Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Buprenorphine Transdermal Patches Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Buprenorphine Transdermal Patches
3.4 Market Concentration Rate
3.4.1 Top 3 Buprenorphine Transdermal Patches Manufacturer Market Share
3.4.2 Top 6 Buprenorphine Transdermal Patches Manufacturer Market Share
3.5 Global Buprenorphine Transdermal Patches Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Buprenorphine Transdermal Patches Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Buprenorphine Transdermal Patches Market Size by Region
4.1.1 Global Buprenorphine Transdermal Patches Sales in Volume by Region (2016-2026)
4.1.2 Global Buprenorphine Transdermal Patches Revenue by Region (2016-2026)
4.2 North America Buprenorphine Transdermal Patches Revenue (2016-2026)
4.3 Europe Buprenorphine Transdermal Patches Revenue (2016-2026)
4.4 Asia-Pacific Buprenorphine Transdermal Patches Revenue (2016-2026)
4.5 South America Buprenorphine Transdermal Patches Revenue (2016-2026)
4.6 Middle East and Africa Buprenorphine Transdermal Patches Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Buprenorphine Transdermal Patches Sales in Volume by Type (2016-2026)
5.2 Global Buprenorphine Transdermal Patches Revenue by Type (2016-2026)
5.3 Global Buprenorphine Transdermal Patches Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Buprenorphine Transdermal Patches Sales in Volume by Application (2016-2026)
6.2 Global Buprenorphine Transdermal Patches Revenue by Application (2016-2026)
6.3 Global Buprenorphine Transdermal Patches Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Buprenorphine Transdermal Patches Sales by Type (2016-2026)
7.2 North America Buprenorphine Transdermal Patches Sales by Application (2016-2026)
7.3 North America Buprenorphine Transdermal Patches Market Size by Country
7.3.1 North America Buprenorphine Transdermal Patches Sales in Volume by Country (2016-2026)
7.3.2 North America Buprenorphine Transdermal Patches Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Buprenorphine Transdermal Patches Sales by Type (2016-2026)
8.2 Europe Buprenorphine Transdermal Patches Sales by Application (2016-2026)
8.3 Europe Buprenorphine Transdermal Patches Market Size by Country
8.3.1 Europe Buprenorphine Transdermal Patches Sales in Volume by Country (2016-2026)
8.3.2 Europe Buprenorphine Transdermal Patches Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Buprenorphine Transdermal Patches Sales by Type (2016-2026)
9.2 Asia-Pacific Buprenorphine Transdermal Patches Sales by Application (2016-2026)
9.3 Asia-Pacific Buprenorphine Transdermal Patches Market Size by Region
9.3.1 Asia-Pacific Buprenorphine Transdermal Patches Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Buprenorphine Transdermal Patches Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Buprenorphine Transdermal Patches Sales by Type (2016-2026)
10.2 South America Buprenorphine Transdermal Patches Sales by Application (2016-2026)
10.3 South America Buprenorphine Transdermal Patches Market Size by Country
10.3.1 South America Buprenorphine Transdermal Patches Sales in Volume by Country (2016-2026)
10.3.2 South America Buprenorphine Transdermal Patches Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Buprenorphine Transdermal Patches Sales by Type (2016-2026)
11.2 Middle East & Africa Buprenorphine Transdermal Patches Sales by Application (2016-2026)
11.3 Middle East & Africa Buprenorphine Transdermal Patches Market Size by Country
11.3.1 Middle East & Africa Buprenorphine Transdermal Patches Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Buprenorphine Transdermal Patches Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Buprenorphine Transdermal Patches Typical Distributors
12.3 Buprenorphine Transdermal Patches Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Buprenorphine Transdermal Patches Revenue by Type, (USD Million), 2021-2026
Table 2. Global Buprenorphine Transdermal Patches Revenue by Application, (USD Million), 2021-2026
Table 3. Grunenthal Basic Information, Manufacturing Base and Competitors
Table 4. Grunenthal Major Business
Table 5. Grunenthal Buprenorphine Transdermal Patches Product and Services
Table 6. Grunenthal Buprenorphine Transdermal Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. PurduePharma Basic Information, Manufacturing Base and Competitors
Table 8. PurduePharma Major Business
Table 9. PurduePharma Buprenorphine Transdermal Patches Product and Services
Table 10. PurduePharma Buprenorphine Transdermal Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Luye Pharma Major Business
Table 13. Luye Pharma Buprenorphine Transdermal Patches Product and Services
Table 14. Luye Pharma Buprenorphine Transdermal Patches Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global Buprenorphine Transdermal Patches Sales by Manufacturer (2019-2021e) & (K Units)
Table 16. Global Buprenorphine Transdermal Patches Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in Buprenorphine Transdermal Patches, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global Buprenorphine Transdermal Patches Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Buprenorphine Transdermal Patches Production Site of Key Manufacturer
Table 20. Global Buprenorphine Transdermal Patches Sales by Region (2016-2021e) & (K Units)
Table 21. Global Buprenorphine Transdermal Patches Sales by Region (2021-2026) & (K Units)
Table 22. Global Buprenorphine Transdermal Patches Revenue by Region (2016-2021e) & (USD Million)
Table 23. Global Buprenorphine Transdermal Patches Revenue by Region (2021-2026) & (USD Million)
Table 24. Global Buprenorphine Transdermal Patches Sales by Type (2016-2021e) & (K Units)
Table 25. Global Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (K Units)
Table 26. Global Buprenorphine Transdermal Patches Revenue by Type (2016-2021e) & (USD Million)
Table 27. Global Buprenorphine Transdermal Patches Revenue by Type (2021-2026) & (USD Million)
Table 28. Global Buprenorphine Transdermal Patches Price by Type (2016-2021e) & (US$/Unit)
Table 29. Global Buprenorphine Transdermal Patches Price by Type (2021-2026) & (US$/Unit)
Table 30. Global Buprenorphine Transdermal Patches Sales by Application (2016-2021e) & (K Units)
Table 31. Global Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (K Units)
Table 32. Global Buprenorphine Transdermal Patches Revenue by Application (2016-2021e) & (USD Million)
Table 33. Global Buprenorphine Transdermal Patches Revenue by Application (2021-2026) & (USD Million)
Table 34. Global Buprenorphine Transdermal Patches Price by Application (2016-2021e) & (US$/Unit)
Table 35. Global Buprenorphine Transdermal Patches Price by Application (2021-2026) & (US$/Unit)
Table 36. North America Buprenorphine Transdermal Patches Sales by Country (2016-2021e) & (K Units)
Table 37. North America Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (K Units)
Table 38. North America Buprenorphine Transdermal Patches Revenue by Country (2016-2021e) & (USD Million)
Table 39. North America Buprenorphine Transdermal Patches Revenue by Country (2021-2026) & (USD Million)
Table 40. North America Buprenorphine Transdermal Patches Sales by Type (2016-2021e) & (K Units)
Table 41. North America Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (K Units)
Table 42. North America Buprenorphine Transdermal Patches Sales by Application (2016-2021e) & (K Units)
Table 43. North America Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (K Units)
Table 44. Europe Buprenorphine Transdermal Patches Sales by Country (2016-2021e) & (K Units)
Table 45. Europe Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (K Units)
Table 46. Europe Buprenorphine Transdermal Patches Revenue by Country (2016-2021e) & (USD Million)
Table 47. Europe Buprenorphine Transdermal Patches Revenue by Country (2021-2026) & (USD Million)
Table 48. Europe Buprenorphine Transdermal Patches Sales by Type (2016-2021e) & (K Units)
Table 49. Europe Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (K Units)
Table 50. Europe Buprenorphine Transdermal Patches Sales by Application (2016-2021e) & (K Units)
Table 51. Europe Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (K Units)
Table 52. Asia-Pacific Buprenorphine Transdermal Patches Sales by Region (2016-2021e) & (K Units)
Table 53. Asia-Pacific Buprenorphine Transdermal Patches Sales by Region (2021-2026) & (K Units)
Table 54. Asia-Pacific Buprenorphine Transdermal Patches Revenue by Region (2016-2021e) & (USD Million)
Table 55. Asia-Pacific Buprenorphine Transdermal Patches Revenue by Region (2021-2026) & (USD Million)
Table 56. Asia-Pacific Buprenorphine Transdermal Patches Sales by Type (2016-2021e) & (K Units)
Table 57. Asia-Pacific Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (K Units)
Table 58. Asia-Pacific Buprenorphine Transdermal Patches Sales by Application (2016-2021e) & (K Units)
Table 59. Asia-Pacific Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (K Units)
Table 60. South America Buprenorphine Transdermal Patches Sales by Country (2016-2021e) & (K Units)
Table 61. South America Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (K Units)
Table 62. South America Buprenorphine Transdermal Patches Revenue by Country (2016-2021e) & (USD Million)
Table 63. South America Buprenorphine Transdermal Patches Revenue by Country (2021-2026) & (USD Million)
Table 64. South America Buprenorphine Transdermal Patches Sales by Type (2016-2021e) & (K Units)
Table 65. South America Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (K Units)
Table 66. South America Buprenorphine Transdermal Patches Sales by Application (2016-2021e) & (K Units)
Table 67. South America Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (K Units)
Table 68. Middle East & Africa Buprenorphine Transdermal Patches Sales by Country (2016-2021e) & (K Units)
Table 69. Middle East & Africa Buprenorphine Transdermal Patches Sales by Country (2021-2026) & (K Units)
Table 70. Middle East & Africa Buprenorphine Transdermal Patches Revenue by Country (2016-2021e) & (USD Million)
Table 71. Middle East & Africa Buprenorphine Transdermal Patches Revenue by Country (2021-2026) & (USD Million)
Table 72. Middle East & Africa Buprenorphine Transdermal Patches Sales by Type (2016-2021e) & (K Units)
Table 73. Middle East & Africa Buprenorphine Transdermal Patches Sales by Type (2021-2026) & (K Units)
Table 74. Middle East & Africa Buprenorphine Transdermal Patches Sales by Application (2016-2021e) & (K Units)
Table 75. Middle East & Africa Buprenorphine Transdermal Patches Sales by Application (2021-2026) & (K Units)
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Buprenorphine Transdermal Patches Typical Distributors
Table 79. Buprenorphine Transdermal Patches Typical Customers
List of Figures
Figure 1. Buprenorphine Transdermal Patches Picture
Figure 2. Global Buprenorphine Transdermal Patches Sales Market Share by Type in 2020
Figure 3. 5mcg/h
Figure 4. 7.5mcg/h
Figure 5. 10mcg/h
Figure 6. 15 mcg/h
Figure 7. 20 mcg/h
Figure 8. Global Buprenorphine Transdermal Patches Sales Market Share by Application in 2020
Figure 9. Relieve Cancer Pain
Figure 10. Other
Figure 11. Global Buprenorphine Transdermal Patches Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Buprenorphine Transdermal Patches Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Buprenorphine Transdermal Patches Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Buprenorphine Transdermal Patches Sales (2016-2026) & (K Units)
Figure 33. Global Buprenorphine Transdermal Patches Production Capacity (2016-2026) & (K Units)
Figure 34. Global Buprenorphine Transdermal Patches Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Buprenorphine Transdermal Patches Market Drivers
Figure 36. Buprenorphine Transdermal Patches Market Restraints
Figure 37. Buprenorphine Transdermal Patches Market Trends
Figure 38. Global Buprenorphine Transdermal Patches Sales Market Share by Manufacturer in 2020
Figure 39. Global Buprenorphine Transdermal Patches Revenue Market Share by Manufacturer in 2020
Figure 40. Buprenorphine Transdermal Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Buprenorphine Transdermal Patches Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Buprenorphine Transdermal Patches Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2016-2026)
Figure 44. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2016-2026)
Figure 45. North America Buprenorphine Transdermal Patches Revenue (2016-2026) & (USD Million)
Figure 46. Europe Buprenorphine Transdermal Patches Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Buprenorphine Transdermal Patches Revenue (2016-2026) & (USD Million)
Figure 48. South America Buprenorphine Transdermal Patches Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Buprenorphine Transdermal Patches Revenue (2016-2026) & (USD Million)
Figure 50. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2016-2026)
Figure 51. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2016-2026)
Figure 52. Global Buprenorphine Transdermal Patches Price by Type (2016-2026) & (US$/Unit)
Figure 53. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2016-2026)
Figure 54. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2016-2026)
Figure 55. Global Buprenorphine Transdermal Patches Price by Application (2016-2026) & (US$/Unit)
Figure 56. North America Buprenorphine Transdermal Patches Sales Market Share by Country (2016-2026)
Figure 57. North America Buprenorphine Transdermal Patches Revenue Market Share by Country (2016-2026)
Figure 58. North America Buprenorphine Transdermal Patches Sales Market Share by Type (2016-2026)
Figure 59. North America Buprenorphine Transdermal Patches Sales Market Share by Application (2016-2026)
Figure 60. Europe Buprenorphine Transdermal Patches Sales Market Share by Country (2016-2026)
Figure 61. Europe Buprenorphine Transdermal Patches Revenue Market Share by Country (2016-2026)
Figure 62. Europe Buprenorphine Transdermal Patches Sales Market Share by Type (2016-2026)
Figure 63. Europe Buprenorphine Transdermal Patches Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Buprenorphine Transdermal Patches Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Buprenorphine Transdermal Patches Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Buprenorphine Transdermal Patches Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Buprenorphine Transdermal Patches Sales Market Share by Application (2016-2026)
Figure 68. South America Buprenorphine Transdermal Patches Sales Market Share by Country (2016-2026)
Figure 69. South America Buprenorphine Transdermal Patches Revenue Market Share by Country (2016-2026)
Figure 70. South America Buprenorphine Transdermal Patches Sales Market Share by Type (2016-2026)
Figure 71. South America Buprenorphine Transdermal Patches Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Buprenorphine Transdermal Patches Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のフェンタニル経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Fentanyl Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界のニコチン経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Nicotine Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界のリバスチグミン経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Rivastigmine Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のエストラジオール経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Estradiol Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のエストラジオール経皮システム市場規模・現状・予測（2021年-2027年） Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching…